Tubal ligation exacerbates ovulation‐driven TP53 mutagenesis and p53 signatures by depleting protective menstrual hemoglobin

Documenti analoghi

• Patterns of structural variants within TP53 introns and relocation of the TP53 promoter: a commentary†
  di: Hannah C Beird, et al.
  Pubblicazione: (2024)
• TP53 mutations in urothelial carcinoma: not all one and the same†
  di: Alexis R Barr, et al.
  Pubblicazione: (2024)
• DNA ‐hypermethylated human gastric cancer circumvents apoptosis in the absence of TP53 mutation
  di: Yasunobu Mano, et al.
  Pubblicazione: (2025)
• TP53 disruptive mutation predicts platinum‐based chemotherapy and PD‐1/PD‐L1 blockade response in urothelial carcinoma
  di: Kaifeng Jin, et al.
  Pubblicazione: (2024)
• A 53‐year‐old woman with a 16‐year history of epilepsy
  di: Rong Ge, et al.
  Pubblicazione: (2024)